BACLOFEN | A214374 | RISING PHARMA HOLDINGS INC
Highest NADAC/Unit
$0.0632
per ea
Lowest NADAC/Unit
$0.0332
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16571016901BACLOFEN 5 MG TABLET | $0.0632 | EA | Generic | — | 2026-06-17 |
| 16571017201BACLOFEN 20 MG TABLET | $0.0552 | EA | Generic | — | 2026-06-17 |
| 16571017210BACLOFEN 20 MG TABLET | $0.0552 | EA | Generic | — | 2026-06-17 |
| 16571017250BACLOFEN 20 MG TABLET | $0.0552 | EA | Generic | — | 2026-06-17 |
| 16571017150BACLOFEN 10 MG TABLET | $0.0332 | EA | Generic | — | 2026-06-17 |
| 16571017101BACLOFEN 10 MG TABLET | $0.0332 | EA | Generic | — | 2026-06-17 |
| 16571017110BACLOFEN 10 MG TABLET | $0.0332 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.